Drugs / 99mTc-RWY
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04289532 | Mar 2018 → Jun 2019 | breast cancer | Peking University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 99mTc-RWY | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04289532 ↗ |
| Route | Intravenous | “was injected intravenously” NCT04289532 ↗ |